510(k) Report

FDA applicant

Scopio Labs, Ltd.

Tel Aviv, IL4 decisions2020–20250 recalls

FDA records 4 decisions for Scopio Labs, Ltd. (Tel Aviv, IL) from 2020 to 2025: 3 510(k) clearances and 1 De Novo grant. Most are in product codes JOY (Device, Automated Cell-Locating) and SAL (Device, Automated Cell Locating, Bone Marrow). Its devices cite 4 predicates, 3 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, hematology panel, where it files most

How often FDA has decided Scopio Labs, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2020: 12022: 12024: 12025: 1
2020high 1 (2020) · low 0 (2021)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2020.

FIG. 1 — Scopio Labs, Ltd. by year, 2020–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Scopio Labs, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report